Crossref journal-article
Proceedings of the National Academy of Sciences
Proceedings of the National Academy of Sciences (341)
Abstract

Silencing of gene expression by small interfering RNAs (siRNAs) is rapidly becoming a powerful tool for genetic analysis and represents a potential strategy for therapeutic product development. However, there are no reports of systemic delivery for siRNAs toward treatment of bone-metastatic cancer. Accordingly, we report here that i.v. injection of GL3 luciferase siRNA complexed with atelocollagen showed effective reduction of luciferase expression from bone-metastatic prostate tumor cells developed in mouse thorax, jaws, and/or legs. We also show that the siRNA/atelocollagen complex can be efficiently delivered to tumors 24 h after injection and can exist intact at least for 3 days. Furthermore, atelocollagen-mediated systemic administration of siRNAs such as enhancer of zeste homolog 2 and phosphoinositide 3′-hydroxykinase p110-α-subunit, which were selected as candidate targets for inhibition of bone metastasis, resulted in an efficient inhibition of metastatic tumor growth in bone tissues. In addition, upregulation of serum IL-12 and IFN-α levels was not associated with the in vivo administration of the siRNA/atelocollagen complex. Thus, for treatment of bone metastasis of prostate cancer, an atelocollagen-mediated systemic delivery method could be a reliable and safe approach to the achievement of maximal function of siRNA.

Bibliography

Takeshita, F., Minakuchi, Y., Nagahara, S., Honma, K., Sasaki, H., Hirai, K., Teratani, T., Namatame, N., Yamamoto, Y., Hanai, K., Kato, T., Sano, A., & Ochiya, T. (2005). Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo. Proceedings of the National Academy of Sciences, 102(34), 12177–12182.

Authors 13
  1. Fumitaka Takeshita (first)
  2. Yoshiko Minakuchi (additional)
  3. Shunji Nagahara (additional)
  4. Kimi Honma (additional)
  5. Hideo Sasaki (additional)
  6. Kotaro Hirai (additional)
  7. Takumi Teratani (additional)
  8. Nachi Namatame (additional)
  9. Yusuke Yamamoto (additional)
  10. Koji Hanai (additional)
  11. Takashi Kato (additional)
  12. Akihiko Sano (additional)
  13. Takahiro Ochiya (additional)
References 37 Referenced 309
  1. 10.1038/nature02870
  2. 10.1038/418038a
  3. 10.1038/ng944
  4. 10.1016/S1535-6108(02)00122-8
  5. 10.1038/nbt739
  6. 10.1016/S0022-2836(03)00181-5
  7. 10.1261/rna.5239604
  8. 10.1038/nature03121
  9. Verma, U. N., Surabhi, R. M., Schmaltieg, A., Becerra, C. & Gaynor, R. B. (2003) Clin. Cancer Res. 9, 1291-1300.12684397 / Clin. Cancer Res. (2003)
  10. Filleur, S., Courtin, A., Ait-Si-Ali, S., Guglielmi, J., Merle, C., Harel-Bellan, A., Clezardin, P. & Cabon, F. (2003) Cancer Res. 63, 3919-3922.12873985 / Cancer Res. (2003)
  11. 10.1016/j.bbrc.2003.10.060
  12. 10.1038/sj.onc.1207247
  13. 10.1093/jnci/djh146
  14. 10.1038/9560
  15. 10.1006/bbrc.2001.6133
  16. 10.2174/1566523013348887
  17. 10.1002/jgm.440
  18. 10.1016/j.addr.2003.08.005
  19. 10.1089/104303404322886110
  20. Minakuchi, Y., Takeshita, F., Kosaka, N., Sasaki, H., Yamamoto, Y., Kouno, M., Honma, K., Nagahara, S., Hanai, K., Sano, A., et al. (2004) Nucleic Acids Res. 32, e109.15272050 (10.1093/nar/gnh093) / Nucleic Acids Res. (2004)
  21. 10.1158/0008-5472.CAN-03-2682
  22. 10.1146/annurev.bb.03.060174.001311
  23. 10.1038/35078107
  24. Arguello, F., Furlanetto, R. W., Baggs, R. B., Graves, B. T., Harwell, S. E., Cohen, H. J. & Frantz, C. N. (1992) Cancer Res. 52, 2304-2309.1559233 / Cancer Res. (1992)
  25. 10.1023/B:CLIN.0000006817.25962.87
  26. 10.1023/B:CLIN.0000006815.49932.98
  27. Scanlon, K. J. (2004) Anticancer Res. 24, 501-504.15152950 / Anticancer Res. (2004)
  28. 10.1016/j.bbrc.2003.11.057
  29. 10.1038/nbt831
  30. 10.1038/ng1173
  31. 10.1038/nbt1038
  32. 10.2165/00003088-200342130-00002
  33. 10.1038/nm1002
  34. 10.1038/nature01075
  35. 10.1146/annurev.cellbio.17.1.615
  36. 10.1073/pnas.1933744100
  37. 10.4161/cbt.3.8.994
Dates
Type When
Created 20 years ago (Aug. 9, 2005, 10:53 p.m.)
Deposited 3 years, 4 months ago (April 12, 2022, 2:21 p.m.)
Indexed 4 days ago (Aug. 26, 2025, 2:29 a.m.)
Issued 20 years ago (Aug. 9, 2005)
Published 20 years ago (Aug. 9, 2005)
Published Online 20 years ago (Aug. 9, 2005)
Published Print 20 years ago (Aug. 23, 2005)
Funders 0

None

@article{Takeshita_2005, title={Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo}, volume={102}, ISSN={1091-6490}, url={http://dx.doi.org/10.1073/pnas.0501753102}, DOI={10.1073/pnas.0501753102}, number={34}, journal={Proceedings of the National Academy of Sciences}, publisher={Proceedings of the National Academy of Sciences}, author={Takeshita, Fumitaka and Minakuchi, Yoshiko and Nagahara, Shunji and Honma, Kimi and Sasaki, Hideo and Hirai, Kotaro and Teratani, Takumi and Namatame, Nachi and Yamamoto, Yusuke and Hanai, Koji and Kato, Takashi and Sano, Akihiko and Ochiya, Takahiro}, year={2005}, month=aug, pages={12177–12182} }